Becoming a Leading Integrated Service Provider

We believe that we have a unique capability to connect our expertise in biotech, fine chemistry, formulation and application technology, delivery systems, microbial control, and regulatory and quality requirements, which allows Lonza to provide the best solutions for our customers to meet some of the world's greatest challenges.

At Lonza we strive for integrated offerings across technologies and along the entire Contract Development and Manufacturing Organization (CDMO) value chain to leverage synergies in technologies and know-how in order to provide full-service offerings to our customers in the pharma and health markets – from gene to patient, from nutritional ingredient to consumer and from microbial control to safe surroundings.

The Capsugel acquisition in July 2017 represented a major leap forward in our strategic quest to become the world’s leading integrated solutions provider across the healthcare continuum.
 

More Information on Leading Integrated Service Provider for Pharma and Health Markets

Adding Capsugel to Create an Integrated Service Provider for the Healthcare Continuum

Capitalizing on Our Strategic Fit

Leveraging Early Commercial Synergies

 

 

 

 

 

 

 

 

 

 

• Letter to Stakeholders
• Highlights of the Business Year 2017
• Financial Highlights
• Value Creation Along and Beyond the Healthcare Continuum
  • Serving Along and Beyond the Healthcare Continuum
  • Becoming a Leading Integrated Service Provider
  • Highlighting Our Initiatives in 2017
• Showing How We Create Value
• Management and Company Structure
• Corporate Governance and Remuneration Policy
• Corporate Responsibility Insights
• Investor Information